Procyanidin B2 Attenuates Sepsis-Induced Acute Lung Injury via Regulating Hippo/Rho/PI3K/NF-κB Signaling Pathway
International Journal of Molecular Sciences · 27.04.2023 · 24 (9) · 7930
DOI: 10.3390/ijms24097930 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.04.2023. Verfasst von Go Oun Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Republic of Korea. Hauptthemen laut MEDLINE: Acute Lung Injury, Sepsis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: a grant from the Korea Health Technology R&D Project through the Korea Health Industry De-velopment Institute (KHIDI), funded by the Ministry of Health & Welfa…, National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT), Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI).
Themen: Sepsis
Abstract (Originalsprache)
Acute lung injury (ALI) is a frequent and challenging aspect of sepsis that currently lacks effective treatments. Procyanidin B2 (PB2) has anti-inflammatory and antioxidant properties. The aim of this study was to determine the effectiveness and mechanism of action of PB2 in treating sepsis-induced ALI using animal experiments. A sepsis-induced ALI mouse model was used by administering lipopolysaccharide (LPS) and then evaluating the levels of inflammatory cytokines and lung injury through measurements of cytokine levels using enzyme-linked immunosorbent assay (ELISA), Western blot and real-time PCR, as well as by the examination of relevant signaling pathways. The animal experiments showed that PB2 protected the lungs from injury caused by LPS and reduced the levels of various inflammatory cytokines in both the serum and lung tissue. Western blot analysis showed that PB2 reduced the expression of TLR4/NF-κB and increased the expression of PI3K/Akt, and also inhibited the Hippo and Rho signaling pathways. The results of the study showed that PB2 helps to treat sepsis-induced ALI by controlling cytokine storms and reducing inflammation by altering the expressions of the TLR4/NF-κB, PI3K/Akt, Hippo and Rho signaling pathways. This research provides a foundation for the further investigation of PB2’s mechanism and its potential use in treating sepsis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.
- Department of Ophthalmology, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu 41944, Republic of Korea.
ORCID-Profile: Jong-Sup Bae
Förderung
- a grant from the Korea Health Technology R&D Project through the Korea Health Industry De-velopment Institute (KHIDI), funded by the Ministry of Health & Welfa…
- National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT)
- Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)
- Ministry of Health & Welfare, Republic of Korea
- National Research Foundation of Korea (NRF)
- Korean government (MSIT)
Zitieren
APA
Kim, G. O., Park, D. H., & Bae, J. S. (2023). Procyanidin B2 Attenuates Sepsis-Induced Acute Lung Injury via Regulating Hippo/Rho/PI3K/NF-κB Signaling Pathway. International Journal of Molecular Sciences, 24(9), 7930. https://doi.org/10.3390/ijms24097930
Vancouver
Kim GO, Park DH, Bae JS. Procyanidin B2 Attenuates Sepsis-Induced Acute Lung Injury via Regulating Hippo/Rho/PI3K/NF-κB Signaling Pathway. International Journal of Molecular Sciences. 2023;24(9):7930. doi:10.3390/ijms24097930
BibTeX
@article{Kim2023,
author = {Kim, Go Oun and Park, Dong Ho and Bae, Jong-Sup},
title = {Procyanidin B2 Attenuates Sepsis-Induced Acute Lung Injury via Regulating Hippo/Rho/PI3K/NF-κB Signaling Pathway},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {9},
pages = {7930},
doi = {10.3390/ijms24097930}
}
EUVIMED